期刊
NANOMEDICINE
卷 4, 期 5, 页码 541-555出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.09.37
关键词
Alzheimer's disease; amyotrophic lateral sclerosis; fullerene; nanomedicine; nanoparticles; neurodegeneration; neuroregeneration; Parkinson's disease; stroke
资金
- Frances and Louie Blumkin Foundation
- Community Neuroscience Pride of Nebraska Research Initiative
- Alan Baer Charitable Trust
- NIH [5P01NS31492, 2R37 NS36126, 2R01 NS034239, P20RR15635, U54NS43011, P01MH64570, P01 NS43985]
Degenerative and inflammatory diseases of the CNS include, but are not limited to, Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis, stroke, multiple sclerosis and HIV-1-associated neurocognitive disorders. These are common, debilitating and, unfortunately, hold few therapeutic options. In recent years, the application of nanotechnologies as commonly used or developing medicines has served to improve pharmacokinetics and drug delivery specifically to CNS-diseased areas. In addition, nanomedical advances are leading to therapies that target CNS pathobiology and as such, can interrupt disordered protein aggregation, deliver functional neuroprotective proteins and alter the oxidant state of affected neural tissues. This article focuses on the pathobiology of common neurodegenerative disorders with a view towards how nanomedicine may be used to improve the clinical course of neurodegenerative disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据